Felipe Soto, Luis F. Torre-Sada, Frank E. Mott, Sang T. Kim, Roza Nurieva, Vickie R. Shannon, Saadia A. Faiz, Roberto F. Casal, Mehmet Altan, Julie Lin, Ajay Sheshadri

Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer

Mauro Di Pilato, Yun Gao, Yi Sun, Amina Fu, Carina Grass, Thomas Seeholzer, Regina Feederle, Irina Mazo, Samuel W. Kazer, Kevin Litchfield, Ulrich H. von Andrian, Thorsten R. Mempel, Russell W. Jenkins, Daniel Krappmann, Peter Keller

COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review

Juan I. Ruiz, Maria A. Lopez-Olivo, Yimin Geng, Maria E. Suarez-Almazor

Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors

Zainab Fatima, Abdulrahman Abonofal, Bettzy Stephen

The Contemporary Landscape and Future Directions of Intratumoral Immunotherapy

Sebastian Brito-Orama, Rahul A. Sheth

Issues

RESEARCH ARTICLES

Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer

REVIEW ARTICLES

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors

CASE REPORTS

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus

Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver

Cover Image

Get Email Alerts

This Feature Is Available To Subscribers Only